The Role of Glucagon-Like Peptide-1 Receptor Agonists in Cognitive Decline and Dementia Prevention: A Systematic Review and Semiquantitative Synthesis

Dementia, particularly Alzheimer’s disease (AD), is a major global health challenge with limited treatment options. Growing evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus (T2DM), may offer neuroprotective benefits by im...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Dharmendra Kumar Gupta, Arunima Chaudhuri
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wolters Kluwer Medknow Publications 2025-07-01
Ráidu:	Journal of Mental Health and Human Behaviour
Fáttát:	alzheimer’s disease cognitive decline dementia prevention glucagon-like peptide-1 receptor agonists neuroprotection type 2 diabetes mellitus
Liŋkkat:	https://journals.lww.com/10.4103/jmhhb.jmhhb_71_25
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!